Latest 5 stories · newest Nov 4, 2026
Perrigo lowered its full-year 2026 outlook due to Europe's softness and measured retail inventory positioning, although the company reported sequential market share gains and higher adjusted earnings in Q3 2026.
Perrigo Co. has agreed to sell its Infant Formula business to MeridianMade for up to $175 million to advance its Streamline Pillar and focus more on consumer self-care products.
Perrigo reported lower Q2 sales and margins but reaffirmed 2026 guidance, citing sequential improvement and portfolio streamlining via the sale of its Dermacosmetics business.
Perrigo Company plc announced the appointment of two new independent directors, Salman Amin and Omer Gajial, effective June 30, 2026. These additions are expected to strengthen the board's expertise in consumer products, retail, and digital transformation.
Perrigo's Board appointed board member Albert Manzone as interim President and CEO effective immediately, following Patrick Lockwood-Taylor's resignation due to personal conduct violations unrelated to business operations. The company reaffirmed its full-year 2026 guidance and initiated a search for…
The same PRGO feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/PRGO/newsSTART FREE